NCT05114330 Secondary Central Nervous System Lymphoma Registry - Charité
| NCT ID | NCT05114330 |
| Status | Unknown |
| Phase | — |
| Sponsor | Charite University, Berlin, Germany |
| Condition | Central Nervous System Lymphoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2011-06-08 |
| Primary Completion | 2024-06-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2011-06-08 with a primary completion date of 2024-06-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of the observation is to collect and document data on treatment strategies for secondary central nervous system lymphoma (SCNSL) in routine clinical practice, whether obtained in the context of clinical trials or outside of trials. In particular, the following questions will be specified: * What therapeutic approaches are being pursued? * What is the clinical outcome of the various treatment options? * What is the frequency of serious adverse events with each therapeutic approach?
Eligibility Criteria
Inclusion Criteria: • All patients with SCNSL can and should be included in the registry regardless of which treatment options are used and whether the treatment being given is first-line, recurrence, or maintenance therapy for SCNSL. Exclusion Criteria: • None
Contact & Investigator
Stefan Habringer, MD
✉ stefan.habringer@charite.deFrequently Asked Questions
Who can join the NCT05114330 clinical trial?
This trial is open to participants of all sexes, studying Central Nervous System Lymphoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05114330 currently recruiting?
NCT05114330 is currently listed as "Unknown" and is not actively enrolling. Check ClinicalTrials.gov for the latest status updates.
Where is the NCT05114330 trial being conducted?
This trial is being conducted at Berlin, Germany.
Who is sponsoring the NCT05114330 clinical trial?
NCT05114330 is sponsored by Charite University, Berlin, Germany. The trial plans to enroll 300 participants.